Tuesday, October 27, 2009

Icagen asthma drug senicapoc trial fails - Forbes


Icagen asthma drug senicapoc trial fails
Forbes
Icagen ( ICGN - news - people ) shares sank 44 percent in after-hours trading, falling 34 cents to 43 cents, after finishing regular trading down 6 cents, ...

and more »

No comments:

Post a Comment